Journal of Clinical Virology

1. Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): Ngee Keong Tan, Cindy P. Madona, Joshua F. Taylor, Lynda Hadjilah Fourali, Jasveen K. Sehmi, Madeline J. Stone, Marcus J. Pond, Penelope R. Cliff, Cassie F. Pope

2. Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): Thomas Perkmann, Patrick Mucher, Darlene Ösze, Antonia Müller, Nicole Perkmann-Nagele, Thomas Koller, Astrid Radakovics, Ines Flieder, Manuela Repl, Rodrig Marculescu, Michael Wolzt, Oswald F. Wagner, Christoph J. Binder, Helmuth Haslacher

3. Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): Irene Görzer, Frederik Haupenthal, Fabrizio Maggi, Fanny Gelas, Dorian Kulifaj, Ludovic Brossault, Elisabeth Puchhammer-Stöckl, Gregor Bond

4. SARS-CoV-2 antigen tests for screening of healthcare workers; experience with over 48,000 combined antigen tests and RT-PCR tests

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): A. Piek, M. Knoester, L. Gard, M. Lokate, H.G.M. Niesters, C.L. van Leer-Buter

5. Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): Katharine Uhteg, Heba H. Mostafa

6. Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV

   Publication date: January 2023

   Source: Journal of Clinical Virology, Volume 158

   Author(s): Nolan Hassold, Ségolène Brichler, Yamina Gater, Delphine Leclerc, Emmanuel Gordien, Olivier Bouchaud, Etienne Carbonnelle, Frédéric Mechai, Hugues Cordel, Héloïse Delagreverie

7. ESCV/PASCV Membership

   Publication date: December 2022

   Source: Journal of Clinical Virology, Volume 157

   Author(s):

8. Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (2009) 54–60

   Publication date: December 2022

   Source: Journal of Clinical Virology, Volume 157

   Author(s): C.M. Chan, Herman Tse, S.S.Y Wong, P.C.Y Woo, S.K.P. Lau, L. Chen, B.J. Zheng, J.D. Huang, K.Y. Yuen

9. Deep sequencing analysis of clinical samples from patients with acute infectious conjunctivitis during the COVID-19 delta surge in Madurai, India

   Publication date: December 2022

   Source: Journal of Clinical Virology, Volume 157

   Author(s): Prajna Lalitha, N Venkatesh Prajna, Rameshkumar Gunasekaran, Gonugunta Vishnu Teja, Sankalp S. Sharma, Armin Hinterwirth, Kevin Ruder, Lina Zhong, Cindi Chen, Michael Deiner, ChunHong Huang, Benjamin A. Pinsky, Thomas M. Lietman, Thuy Doan, Gerami D. Seitzman, SCORPIO (Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes) Study Group

10. Outpatient human coronavirus associated conjunctivitis in India

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): N Venkatesh Prajna, Prajna Lalitha, Gonugunta Vishnu Teja, Rameshkumar Gunasekaran, Sankalp S. Sharma, Armin Hinterwirth, Kevin Ruder, Lina Zhong, Cindi Chen, Michael Deiner, ChunHong Huang, Benjamin A. Pinsky, Thomas M. Lietman, Gerami D. Seitzman, Thuy Doan, SCORPIO (Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes) Study Group

11. Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Chih-Hsien Chuang, Chung-Guei Huang, Ching-Tai Huang, Yi-Ching Chen, Yu-An Kung, Chih-Jung Chen, Tzu-Chun Chuang, Ching-Chi Liu, Po-Wei Huang, Shu-Li Yang, Po-Wen Gu, Shin-Ru Shih, Cheng-Hsun Chiu

12. Development and characterization of secondary standards for nucleic acid amplification technology (NAAT) assays for detection of hepatitis E virus

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Rafaelle Fares-Gusmao, Zhen Jiang, Sakthivel Subramaniam, Bryan J. Visser, Alysia Scott, Yuji Ishida, Takeshi Saito, Sally A. Baylis, David R. McGivern, Carla Osiowy, Jamie Borlang, Tyler Kosowan, Sally A. Baylis, Roswitha Kleiber, Jürgen J. Wenzel, Mathias Schemmerer, Jasmin Klein, Giulio Pisani, Matteo Simeoni, Antonio Martina

13. Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Yasuko Sagara, Hitomi Nakamura, Masahiro Satake, Toshiki Watanabe, Isao Hamaguchi

14. Sierra SARS-CoV-2 sequence and antiviral resistance analysis program

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Philip L. Tzou, Kaiming Tao, Malaya K. Sahoo, Sergei L. Kosakovsky Pond, Benjamin A. Pinsky, Robert W. Shafer

15. Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Rebecca Jonczyk, Nils Stanislawski, Lisa K. Seiler, Somayeh Ahani, Arne Bueltemeier, Frank Stahl, Sascha Beutel, Holger Blume, Corinna Hauß, Anette Melk, Mira Paulsen, Meike Stiesch, Andreas Winkel, Philipp-Cornelius Pott, Giulietta Saletti, Mariana González-Hernández, Franziska Karola Kaiser, Guus F. Rimmelzwaan, Albert D.M.E. Osterhaus, Cornelia Blume

16. NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Franziska Hielscher, Tina Schmidt, Verena Klemis, Alexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, Urban Sester, Marek Widera, Martina Sester

17. Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Zheng Yan, Zhihua Yao, Haiying Wang, Shuna Yao, Xiaoxiao Wang, Yan Gao, Bing Bai, Junfeng Chu, Shuang Zhao, Xufeng Luo, Wenping Zhou, Jiuyang Zhang, Peipei Zhang, Huiqiang Huang, Yanyan Liu

18. Clinical scoring system to predict viable viral shedding in patients with COVID-19

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Sung Woon Kang, Heedo Park, Ji Yeun Kim, Sunghee Park, So Yun Lim, Sohyun Lee, Joon-Yong Bae, Jeonghun Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Sung-Cheol Yun, Man-Seong Park, Sung-Han Kim

19. Mumps-specific IgG, IgG subclasses and neutralization titres to the vaccine and outbreak mumps strains differ in vaccinated healthy controls, breakthrough mumps infection cases and naturally infected individuals.

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Deirdre Jane Foley, Anna Rose Connell, Gabriel Gonzalez, Jeff Connell, Timothy Ronan Leahy, Cillian De Gascun, Jaythoon Hassan

20. Predictors of unfavorable outcome in children hospitalized with influenza and differences in clinical presentation among serotypes

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Ranaa Damouni Shalabi, Imad Kassis, Moran Szwarcwort Cohen, Halima Dabaja-Younis

21. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Francesca Colavita, Eleonora Lalle, Valentina Mazzotta, Claudia Cimaglia, Jessica Paulicelli, Giulia Matusali, Lavinia Fabeni, Fabrizio Carletti, Silvia Rosati, Serena Vita, Giuseppina Giannico, Pierluca Piselli, Elisa Biliotti, Samir Al Moghazi, Silvia Mosti, Enrico Girardi, Emanuele Nicastri, Anna Rosa Garbuglia

22. COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates)

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s): Wael Hafez

23. Editorial Board

    Publication date: December 2022

    Source: Journal of Clinical Virology, Volume 157

    Author(s):

24. Integrated surveillance of human respiratory viruses in addition to SARS-CoV-2 in a public testing facility in the Netherlands

    Publication date: Available online 26 November 2022

    Source: Journal of Clinical Virology

    Author(s): N.L. Plantinga, M.C.J. van Lanschot, C.F.H. Raven, R. schuurman, A.F. Rirash, B. van Deursen, G.J. Boland, T.O. Siksma, E. Fries, M. Mostert, S.F.T. Thijsen, L.M. Hofstra